| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5944479 | Atherosclerosis | 2015 | 8 Pages |
Abstract
The prevalence of rare LPL variants in patients with severe or moderate HTG, referred to tertiary lipid clinics, was 50/149 (33.5%) and 6/106 (5.6%), respectively. Systematic analysis of relatives of mutation carriers is an efficient way to identify heterozygotes who may develop severe HTG.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Claudio Rabacchi, Livia Pisciotta, Angelo B. Cefalù, Davide Noto, Raffaele Fresa, Patrizia Tarugi, Maurizio Averna, Stefano Bertolini, Sebastiano Calandra,